KR101915031B1 - Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts - Google Patents
Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts Download PDFInfo
- Publication number
- KR101915031B1 KR101915031B1 KR1020180084891A KR20180084891A KR101915031B1 KR 101915031 B1 KR101915031 B1 KR 101915031B1 KR 1020180084891 A KR1020180084891 A KR 1020180084891A KR 20180084891 A KR20180084891 A KR 20180084891A KR 101915031 B1 KR101915031 B1 KR 101915031B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- water
- hours
- coffee
- pomegranate
- Prior art date
Links
- 235000016213 coffee Nutrition 0.000 title claims abstract description 117
- 235000013353 coffee beverage Nutrition 0.000 title claims abstract description 117
- 239000000284 extract Substances 0.000 title claims abstract description 101
- 235000014360 Punica granatum Nutrition 0.000 title claims abstract description 42
- 238000004519 manufacturing process Methods 0.000 title abstract description 20
- 206010027304 Menopausal symptoms Diseases 0.000 title abstract description 11
- 244000294611 Punica granatum Species 0.000 title abstract description 5
- 235000013399 edible fruits Nutrition 0.000 title description 4
- 235000010575 Pueraria lobata Nutrition 0.000 title description 2
- 241000219781 Pueraria montana var. lobata Species 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 86
- 239000000843 powder Substances 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000012141 concentrate Substances 0.000 claims abstract description 20
- 238000000605 extraction Methods 0.000 claims abstract description 18
- 238000002156 mixing Methods 0.000 claims abstract description 18
- 238000001035 drying Methods 0.000 claims abstract description 15
- 239000000052 vinegar Substances 0.000 claims abstract description 12
- 235000021419 vinegar Nutrition 0.000 claims abstract description 12
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 11
- 238000011049 filling Methods 0.000 claims abstract description 8
- 238000005406 washing Methods 0.000 claims abstract description 4
- 241000219991 Lythraceae Species 0.000 claims description 38
- 229940109529 pomegranate extract Drugs 0.000 claims description 21
- 239000000203 mixture Substances 0.000 claims description 15
- 230000008569 process Effects 0.000 claims description 11
- 240000003152 Rhus chinensis Species 0.000 claims description 8
- 235000014220 Rhus chinensis Nutrition 0.000 claims description 8
- 230000006872 improvement Effects 0.000 claims description 8
- 239000012065 filter cake Substances 0.000 claims description 7
- 241001164374 Calyx Species 0.000 claims description 6
- 235000013312 flour Nutrition 0.000 claims description 6
- 241000736285 Sphagnum Species 0.000 claims description 5
- 238000007602 hot air drying Methods 0.000 claims description 5
- 235000021539 instant coffee Nutrition 0.000 claims description 5
- 244000063299 Bacillus subtilis Species 0.000 claims description 4
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 4
- 241000209140 Triticum Species 0.000 claims description 4
- 235000021307 Triticum Nutrition 0.000 claims description 4
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 claims description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 3
- 241000222336 Ganoderma Species 0.000 claims description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 claims 1
- 240000003768 Solanum lycopersicum Species 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract description 5
- 238000010298 pulverizing process Methods 0.000 abstract description 5
- 241000318694 Myosoton aquaticum Species 0.000 abstract 7
- 241001331134 Chrysanthemum zawadskii Species 0.000 abstract 5
- 235000018947 Chrysanthemum zawadskii Nutrition 0.000 abstract 5
- 241000068415 Cynanchum bungei Species 0.000 abstract 5
- 241000913776 Pueraria montana Species 0.000 abstract 4
- 238000010025 steaming Methods 0.000 abstract 2
- 230000000052 comparative effect Effects 0.000 description 49
- 238000002360 preparation method Methods 0.000 description 17
- 238000002835 absorbance Methods 0.000 description 11
- 230000003078 antioxidant effect Effects 0.000 description 11
- 239000000523 sample Substances 0.000 description 11
- 235000019658 bitter taste Nutrition 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 229930003935 flavonoid Natural products 0.000 description 9
- 235000017173 flavonoids Nutrition 0.000 description 9
- 150000002215 flavonoids Chemical class 0.000 description 9
- 238000010438 heat treatment Methods 0.000 description 9
- 235000019640 taste Nutrition 0.000 description 9
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 8
- 239000000796 flavoring agent Substances 0.000 description 8
- 235000019634 flavors Nutrition 0.000 description 8
- 150000002989 phenols Chemical class 0.000 description 8
- 239000008213 purified water Substances 0.000 description 8
- 239000000262 estrogen Substances 0.000 description 7
- 229940011871 estrogen Drugs 0.000 description 7
- 230000002000 scavenging effect Effects 0.000 description 7
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 5
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 5
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 5
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 5
- 235000001368 chlorogenic acid Nutrition 0.000 description 5
- 229940074393 chlorogenic acid Drugs 0.000 description 5
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 5
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 5
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 5
- 239000003075 phytoestrogen Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- 230000002292 Radical scavenging effect Effects 0.000 description 4
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000019901 Anxiety disease Diseases 0.000 description 3
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 208000008454 Hyperhidrosis Diseases 0.000 description 3
- 208000001132 Osteoporosis Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 3
- 230000036506 anxiety Effects 0.000 description 3
- 235000013527 bean curd Nutrition 0.000 description 3
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 3
- 235000005487 catechin Nutrition 0.000 description 3
- 229950001002 cianidanol Drugs 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 229920001864 tannin Polymers 0.000 description 3
- 235000018553 tannin Nutrition 0.000 description 3
- 239000001648 tannin Substances 0.000 description 3
- CUXYLFPMQMFGPL-BGDVVUGTSA-N (9Z,11E,13Z)-octadecatrienoic acid Chemical compound CCCC\C=C/C=C/C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-BGDVVUGTSA-N 0.000 description 2
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 2
- RUFPHBVGCFYCNW-UHFFFAOYSA-N 1-naphthylamine Chemical compound C1=CC=C2C(N)=CC=CC2=C1 RUFPHBVGCFYCNW-UHFFFAOYSA-N 0.000 description 2
- HVBSAKJJOYLTQU-UHFFFAOYSA-N 4-aminobenzenesulfonic acid Chemical compound NC1=CC=C(S(O)(=O)=O)C=C1 HVBSAKJJOYLTQU-UHFFFAOYSA-N 0.000 description 2
- 206010003210 Arteriosclerosis Diseases 0.000 description 2
- 244000020518 Carthamus tinctorius Species 0.000 description 2
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010016825 Flushing Diseases 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 241001633628 Lycoris Species 0.000 description 2
- JEIZLWNUBXHADF-UHFFFAOYSA-N Pelletierine Chemical compound CC(=O)CC1CCCCN1 JEIZLWNUBXHADF-UHFFFAOYSA-N 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 208000011775 arteriosclerosis disease Diseases 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000007979 citrate buffer Substances 0.000 description 2
- 238000009164 estrogen replacement therapy Methods 0.000 description 2
- 239000003163 gonadal steroid hormone Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 230000037315 hyperhidrosis Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 2
- 150000002515 isoflavone derivatives Chemical class 0.000 description 2
- 235000008696 isoflavones Nutrition 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000009245 menopause Effects 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 208000019116 sleep disease Diseases 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- JMGCAHRKIVCLFW-UHFFFAOYSA-N 1-O-Galloylcastalagin Natural products Oc1cc(cc(O)c1O)C(=O)OC2C3OC(=O)c4c2c(O)c(O)c(O)c4c5c(O)c(O)c(O)c6c5C(=O)OC3C7OC(=O)c8cc(O)c(O)c(O)c8c9c(O)c(O)c(O)cc9C(=O)OCC7OC(=O)c%10cc(O)c(O)c(O)c6%10 JMGCAHRKIVCLFW-UHFFFAOYSA-N 0.000 description 1
- DYQDHRLBSZIKEM-UHFFFAOYSA-N 1-[3-(2-acetyl-3,6-dihydroxyphenyl)-2,4-dihydroxyphenyl]ethanone Chemical compound CC(=O)C1=CC=C(O)C(C=2C(=C(O)C=CC=2O)C(C)=O)=C1O DYQDHRLBSZIKEM-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 108091023020 Aldehyde Oxidase Proteins 0.000 description 1
- 102000048262 Aldehyde oxidases Human genes 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- NNDHDYDFEDRMGH-CAEIVAEBSA-N Anthranoyllycoctonine Chemical compound C([C@]12CN(C3[C@@]4(O)[C@]5(O)[C@H]6[C@@H](OC)[C@@H]([C@H](C5)OC)C[C@H]6[C@@]3([C@@H]1[C@@H]4OC)[C@@H](OC)CC2)CC)OC(=O)C1=CC=CC=C1N NNDHDYDFEDRMGH-CAEIVAEBSA-N 0.000 description 1
- 241000208327 Apocynaceae Species 0.000 description 1
- 240000009300 Apodytes dimidiata Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 235000011996 Calamus deerratus Nutrition 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 240000004307 Citrus medica Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000331432 Cynanchum wilfordii Species 0.000 description 1
- PWXVHDBBWJSGOT-UHFFFAOYSA-N Cynandione A Natural products CC(=O)c1ccc(c(O)c1O)-c1c(O)ccc(C(C)=O)c1O PWXVHDBBWJSGOT-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- CQLUYSHACKIUHL-UHFFFAOYSA-N Gagaminine Natural products C1CC(C2(CC=C3CC(O)CCC3(C)C2CC2OC(=O)C=CC=3C=CC=CC=3)O)(O)C2(C)C1(O)C(C)OC(=O)C1=CC=CN=C1 CQLUYSHACKIUHL-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 240000002045 Guettarda speciosa Species 0.000 description 1
- 235000001287 Guettarda speciosa Nutrition 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- UXOXDDUEWZOAIW-UHFFFAOYSA-N Inuline Natural products CCN1CC2(CC(=O)Oc3ccccc3N)CCC(OC)C45C6CC7C(CC(O)(C6C7OC)C(O)(C(OC)C24)C15)OC UXOXDDUEWZOAIW-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010029216 Nervousness Diseases 0.000 description 1
- 206010067572 Oestrogenic effect Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- 101100505672 Podospora anserina grisea gene Proteins 0.000 description 1
- 244000046146 Pueraria lobata Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000589180 Rhizobium Species 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- 241001165494 Rhodiola Species 0.000 description 1
- 241000208225 Rhus Species 0.000 description 1
- 235000010889 Rhus javanica Nutrition 0.000 description 1
- 206010040021 Sensory abnormalities Diseases 0.000 description 1
- 241000533293 Sesbania emerus Species 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- CQLUYSHACKIUHL-LQAUVMAVSA-N [(1s)-1-[(3s,9r,10r,12r,13r,14r,17r)-3,8,14,17-tetrahydroxy-10,13-dimethyl-12-[(e)-3-phenylprop-2-enoyl]oxy-1,2,3,4,7,9,11,12,15,16-decahydrocyclopenta[a]phenanthren-17-yl]ethyl] pyridine-3-carboxylate Chemical compound O([C@@H](C)[C@]1(O)[C@]2(C)[C@](C3(CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3C[C@H]2OC(=O)\C=C\C=2C=CC=CC=2)O)(O)CC1)C(=O)C1=CC=CN=C1 CQLUYSHACKIUHL-LQAUVMAVSA-N 0.000 description 1
- WXYGKQHQSYONAN-MRNPWORGSA-N [(3s,8s,9r,10r,12r,13s,14r,17r)-17-acetyl-8,14,17-trihydroxy-3-[(2r,4s,5r,6r)-5-[(2s,4s,5r,6s)-5-[(2s,4s,5r,6r)-5-[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methylox Chemical compound O1[C@@H](C)[C@H](O)[C@H](OC)C[C@@H]1O[C@H]1[C@@H](OC)C[C@H](O[C@H]2[C@H](C[C@@H](O[C@H]2C)O[C@H]2[C@H](C[C@@H](O[C@@H]2C)O[C@@H]2CC3=CC[C@@]4(O)[C@@]5(O)CC[C@@](O)([C@@]5(C)[C@H](OC(=O)\C=C\C=5C=CC=CC=5)C[C@@H]4[C@@]3(C)CC2)C(C)=O)OC)OC)O[C@@H]1C WXYGKQHQSYONAN-MRNPWORGSA-N 0.000 description 1
- YUDOHRCAEPBFBO-ZNQKHRBLSA-N [(3s,8s,9r,10r,12r,13s,14r,17r)-17-acetyl-8,14,17-trihydroxy-3-[(2r,4s,5r,6r)-5-[(2s,4s,5r,6s)-5-[(2s,4s,5r,6r)-5-[(2s,4r,5s,6s)-5-hydroxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methyloxan-2-yl]oxy-4-methoxy-6-methylox Chemical compound O1[C@@H](C)[C@H](O)[C@H](OC)C[C@@H]1O[C@H]1[C@@H](OC)C[C@H](O[C@H]2[C@H](C[C@@H](O[C@H]2C)O[C@H]2[C@H](C[C@@H](O[C@@H]2C)O[C@@H]2CC3=CC[C@@]4(O)[C@@]5(O)CC[C@@](O)([C@@]5(C)[C@H](OC(=O)\C=C(/C)C(C)C)C[C@@H]4[C@@]3(C)CC2)C(C)=O)OC)OC)O[C@@H]1C YUDOHRCAEPBFBO-ZNQKHRBLSA-N 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- VNRZCPPHNPEBFC-UHFFFAOYSA-N anthranoyllycoctonine Natural products CCN1CC2(COC(=O)c3ccccc3N)CCC(OC)C45C2C(OC)C(O)(C14)C6(O)CC(OC)C7CC5(O)C6C7OC VNRZCPPHNPEBFC-UHFFFAOYSA-N 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- KZNIFHPLKGYRTM-UHFFFAOYSA-N apigenin Chemical compound C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C=C(O)C=C2O1 KZNIFHPLKGYRTM-UHFFFAOYSA-N 0.000 description 1
- XADJWCRESPGUTB-UHFFFAOYSA-N apigenin Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=CC(O)=C(O)C=C2O1 XADJWCRESPGUTB-UHFFFAOYSA-N 0.000 description 1
- 229940117893 apigenin Drugs 0.000 description 1
- 235000008714 apigenin Nutrition 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- VVALLMRFCRQNSH-UHFFFAOYSA-N cynanchone A Natural products COC1(C)Oc2c(O)c(ccc12)c3c(O)ccc(C(=O)C)c3O VVALLMRFCRQNSH-UHFFFAOYSA-N 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
- 229960005156 digoxin Drugs 0.000 description 1
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 229920001968 ellagitannin Polymers 0.000 description 1
- JMGCAHRKIVCLFW-CNWXVVPTSA-N ellagitannin Chemical compound OC1=C(O)C(O)=CC(C(=O)O[C@H]2C3=C4C(=O)O[C@@H]2[C@@H]2[C@@H]5OC(=O)C6=CC(O)=C(O)C(O)=C6C6=C(O)C(O)=C(O)C=C6C(=O)OC[C@H]5OC(=O)C5=CC(O)=C(O)C(O)=C5C=5C(O)=C(O)C(O)=C(C=5C(=O)O2)C4=C(O)C(O)=C3O)=C1 JMGCAHRKIVCLFW-CNWXVVPTSA-N 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 239000003687 estradiol congener Substances 0.000 description 1
- 230000001076 estrogenic effect Effects 0.000 description 1
- 229940106582 estrogenic substances Drugs 0.000 description 1
- JKKFKPJIXZFSSB-CBZIJGRNSA-N estrone 3-sulfate Chemical compound OS(=O)(=O)OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 JKKFKPJIXZFSSB-CBZIJGRNSA-N 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000027950 fever generation Effects 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000010200 folin Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000003779 hair growth Effects 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000002657 hormone replacement therapy Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229930013686 lignan Natural products 0.000 description 1
- 235000009408 lignans Nutrition 0.000 description 1
- 150000005692 lignans Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000019645 odor Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 229940124595 oriental medicine Drugs 0.000 description 1
- -1 phenol compound Chemical class 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- SSIRGMIVWUBXFB-UHFFFAOYSA-N punicalin Natural products OC1OC2COC(=O)c3cc(O)c(O)c(O)c3c4c(O)c(O)c5OC(=O)c6c(c(O)c(O)c7OC(=O)c4c5c67)c8cc(C(=O)OC2C(O)C1O)c(O)c(O)c8O SSIRGMIVWUBXFB-UHFFFAOYSA-N 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 208000022925 sleep disturbance Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229930002534 steroid glycoside Natural products 0.000 description 1
- 150000008143 steroidal glycosides Chemical class 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229950000244 sulfanilic acid Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- CUXYLFPMQMFGPL-UYWAGRGNSA-N trichosanic acid Natural products CCCCC=C/C=C/C=CCCCCCCCC(=O)O CUXYLFPMQMFGPL-UYWAGRGNSA-N 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- YUDOHRCAEPBFBO-UHFFFAOYSA-N wilfoside C(1)N Natural products O1C(C)C(O)C(OC)CC1OC1C(OC)CC(OC2C(CC(OC2C)OC2C(CC(OC2C)OC2CC3=CCC4(O)C5(O)CCC(O)(C5(C)C(OC(=O)C=C(C)C(C)C)CC4C3(C)CC2)C(C)=O)OC)OC)OC1C YUDOHRCAEPBFBO-UHFFFAOYSA-N 0.000 description 1
- YUDOHRCAEPBFBO-KXNNMBJLSA-N wilfoside C1N Natural products CO[C@@H]1C[C@H](O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2OC)O[C@@H]2[C@H](C)O[C@H](C[C@@H]2OC)O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2OC)O[C@H]2CC[C@]3(C)[C@H]4C[C@@H](OC(=O)C=C(C)C(C)C)[C@]5(C)[C@@](O)(CC[C@]5(O)[C@]4(O)CC=C3C2)C(C)=O)O[C@@H](C)[C@@H]1O YUDOHRCAEPBFBO-KXNNMBJLSA-N 0.000 description 1
- WXYGKQHQSYONAN-UHFFFAOYSA-N wilfoside K 1N Natural products O1C(C)C(O)C(OC)CC1OC1C(OC)CC(OC2C(CC(OC2C)OC2C(CC(OC2C)OC2CC3=CCC4(O)C5(O)CCC(O)(C5(C)C(OC(=O)C=CC=5C=CC=CC=5)CC4C3(C)CC2)C(C)=O)OC)OC)OC1C WXYGKQHQSYONAN-UHFFFAOYSA-N 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
- A23F5/26—Extraction of water-soluble constituents
- A23F5/267—Extraction of water-soluble constituents using additives, specific extraction media or specific coffee blends
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
- A23F5/26—Extraction of water-soluble constituents
- A23F5/262—Extraction of water-soluble constituents the extraction liquid flows through a stationary bed of solid substances, e.g. in percolation columns
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/24—Extraction of coffee; Coffee extracts; Making instant coffee
- A23F5/28—Drying or concentrating coffee extract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F5/00—Coffee; Coffee substitutes; Preparations thereof
- A23F5/46—Coffee flavour; Coffee oil; Flavouring of coffee or coffee extract
- A23F5/465—Flavouring with flavours other than natural coffee flavour or coffee oil
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/10—Drying, dehydrating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2300/00—Processes
- A23V2300/14—Extraction
Abstract
Description
본 발명은 백수오 추출액, 구절초 추출액, 칡 추출액, 쇠별꽃 추출액 및 석류 추출액을 혼합한 혼합 추출액을 이용한 여성 갱년기 개선을 위한 더치커피의 제조방법 및 상기 방법으로 제조된 여성 갱년기 개선을 위한 더치커피에 관한 것이다.The present invention relates to a process for producing Dutch coffee for improving the female menopausal period using a mixed extract obtained by mixing Baekgoo extract, Rhus herb extract, Rhizopus extract, Calyx extract and Pomegranate extract, and Dutch coffee for the improvement of female menopause will be.
꼭두서니과(Rubiaceae) 코페아속(Coffee)에 속하는 커피는 전 세계적으로 가장 많이 소비되는 기호 음료이다. 커피에는 다른 식품에 비해 폴리페놀 등의 항산화 성분 함량이 높아 세포 손상을 유발하는 자유라디칼 소거능이 높다고 알려져 있으며, 최근에는 신경세포 보호효과를 갖는 친유성 항산화 물질(lipophilic antioxidant)과 클로로겐산(chlorogenic acid) 등이 커피 생두보다 로스팅한 원두커피에 높은 함량을 나타낸다는 결과도 보고되고 있다. 또한, 커피는 알츠하이머, 파킨슨병, 제2형 당뇨병, 콜레스테롤, 심장 질환 및 간경변 등에도 우수한 보호효과를 갖는 것으로 알려지면서 기호식품을 넘어서 커피의 약리적인 효과에도 많은 연구가 이루어지고 있는 추세이다. Coffee belonging to the Rubiaceae coffee belongs to the most commonly consumed beverage in the world. It is known that coffee has high free radical scavenging ability to cause cell damage due to high content of antioxidants such as polyphenols as compared with other foods. Recently, lipophilic antioxidant and chlorogenic acid, The results of this study are as follows. In addition, coffee has been known to have an excellent protective effect on Alzheimer's, Parkinson's disease, type 2 diabetes, cholesterol, heart disease and cirrhosis.
커피를 섭취하는 방법 중 뜨거운 물이 아닌 찬물 또는 상온의 물을 이용하여 장시간에 걸쳐 커피를 우려내어 마시는 커피를 더치커피라 하는데, 더치커피라는 명칭은 네덜란드풍(Dutch)의 커피라 하여 붙여진 일본식 명칭이고, 영어로는 '차가운 물에 우려낸다'는 뜻으로 콜드 브루(cold brew)라고 한다. 더치커피는 오랜 시간에 걸쳐 추출하기 때문에 뜨거운 물로 짧은 시간에 추출한 일반 커피에 비하여 쓴맛이 덜하며 순하고 부드러운 풍미를 느낄 수 있는데, 원두의 분쇄 정도와 물의 맛, 추출 시간이 중요한 작용을 한다. 추출된 커피 원액은 밀봉해서 냉장 보관하는데, 하루 이틀 정도 저온 숙성하면 풍미가 더 살아난다.Among the methods of consuming coffee, coffee is called "coffee" and "coffee" is a coffee called "Dutch coffee." The name "Dutch coffee" refers to the Japanese name "Dutch coffee" Cold brew "in English meaning" cold water ". Because hot coffee extracts over a long period of time, it is less bitter than ordinary coffee extracted in a short time with hot water. You can feel soft and tender flavor. The degree of grinding of bean, taste of water and extraction time are important. The extracted coffee liquid is stored in a sealed refrigerator. If it is matured for a day or two at a low temperature, the flavor will survive more.
백하수오는 박주가리과(Asclepiadaceae)에 속하는 다년생 덩굴식물인 은조롱(Cynanchum wilfordii Hemsley)의 뿌리로 우리나라가 주산지이다. 백하수오의 주요 기능 성분으로 포스파티딜콜린(phosphatidyl choline), 포스파티딜에탄올아민(phosphatidyl ethanolamine), 포스파티딜이노시톨(phosphatidyl inositol) 등의 인지질과 hepatic aldehyde oxidase에 대한 억제 활성을 갖는 가가미닌(gagaminine), 항산화 활성의 시난디온(cynandione) A 및 시난초네(cynanchone) A, 그 외에 스테로이드의 글리코시드(steroidal glycoside)로 윌포사이드(wilfoside) K1N, 윌포사이드(wilfoside) C1N 등이 있다. 주요 효능으로는 항노화 효과와 자양, 강장, 보혈작용, 동맥경화 억제 효과, 고지혈증 및 당뇨예방 개선 효과, 혈관이완 효과, 에탄올 추출물에 의한 멜라닌 생성 억제 효과, 모발성장 효과 등의 연구 결과가 보고되었다.It is the roots of Cynanchum wilfordii Hemsley, a perennial vine plant belonging to Asclepiadaceae, which is the main product of our country. The main functional components of white seaweeds are phosphatidylcholine, phosphatidyl ethanolamine, phosphatidyl inositol, phosphatidylglycerol, and gagaminine, which have antioxidant activity against hepatic aldehyde oxidase. Cynandione A and cynanchone A, and steroidal glycosides of steroids such as wilfoside K1N and wilfoside C1N. Major efficacy studies have been reported on anti-aging effects, nourishment, tamponade, blood circulation, arteriosclerosis inhibitory effect, hyperlipidemia and diabetes prevention improvement effect, vascular relaxation effect, melanin production inhibitory effect by ethanol extract, hair growth effect .
석류(Punica granatum L., Pomegranate)는 석류과(Punicaceae)에 속하는 낙엽성 소목의 열매로 이란을 중심으로 아열대 및 열대 각지에 널리 퍼져 있는 식물이다. 예부터 촌충의 구제, 설사, 이질, 구내염, 장출혈에 효과가 있는 것으로 알려져, 석류열매와 줄기껍질, 그리고 뿌리껍질을 건조하여 한약재로 많이 쓰여 왔으며, 근래에는 고혈압과 동맥경화, 항산화, 항염증, 항암 등의 임상적 효능을 가진 90여 종의 생리활성물질이 함유되어 있는 것으로 보고되어 있다. 석류의 주요 성분은 알칼로이드인 이소펠레티에린(isopelletierine)이며, 그 외 타닌인 퓨니칼린(punicalin), 이눌린(inuline), 만니톨(mannitol), 소르비톨(sorbitol), 말산(malic acid) 등이 함유되어 있다. 석류나무의 수피, 잎, 과피에는 에라지타닌(ellagitannin)과 갈로타닌(gallotanin)이 풍부하고, 잎에는 아피게닌(apigenin), 루테인(lutein) 등의 배당체가 함유되어 있다. 또한, 석류는 과즙보다 껍질과 씨 부분에 기능성 성분의 함량뿐만 아니라, 항암 및 항산화 활성이 높으며, 여성호르몬인 에스트로겐 대응 물질도 많이 포함되어 있는 것으로 밝혀졌다. 최근 석류씨 중의 푸닉산(punicic acid), 에스트로겐(estrogen), 에스트라디올(estradiol), β-시토스테롤(β-sitosterol)의 생리활성 및 섭취 효과가 보고되면서 석류씨에 대한 많은 연구들이 발표되고 있다. 석류나 콩과류에서 발견되는 피토에스트로겐(phytoestrogen)의 주성분은 이소플라본과 리그난 등의 페놀성 화합물이며, 이들 페놀성 화합물은 천연의 성호르몬과 공통성을 갖는 구조를 가지고 있어 암, 심장혈관질환, 골다공증 등의 만성질환에 대해서 예방 효과가 있다고 보고되고 있다. Pomegranate ( Punica granatum L., Pomegranate) is a fruit of deciduous joist belonging to the pomegranate family (Punicaceae) and is widely distributed in the subtropical and tropical regions around Iran. It has been known that it is effective for relieving tapeworms, diarrhea, dysentery, stomatitis and intestinal hemorrhage, and drying pomegranate fruit, stem skin, and root skin and has been widely used as medicinal herbs. Recently, hypertension, arteriosclerosis, It is reported that 90 kinds of physiologically active substances having clinical efficacy such as anti-cancer are contained. The main component of the pomegranate is the alkaloid isopelletierine, and other tannins include punicalin, inuline, mannitol, sorbitol, malic acid, and the like. have. The pomegranate bark, leaves and rind are rich in ellagitannin and gallotanin, and leaves contain glycosides such as apigenin and lutein. In addition, the pomegranate has higher anticancer and antioxidant activity as well as the content of functional ingredients in the skin and seed part than the juice, and it is found that the pomegranate also contains a lot of estrogen counterparts that are female hormones. Recently, many studies on pomegranate seeds have been published with reports on the physiological activity and intake effects of punicic acid, estrogen, estradiol, and β-sitosterol in pomegranate seeds. The major components of phytoestrogen found in pomegranate and soybean flour are phenolic compounds such as isoflavones and lignans. These phenolic compounds have a structure common to natural sex hormones, Have been reported to have a preventive effect against chronic diseases such as osteoporosis.
칡(Pueraria hirsuta Matsum)은 우리나라를 비롯하여 동남아 각지에서 자생하는 두과(Leguminosae) 식물로, 그 뿌리는 약 16~19%가 전분으로 구성되어 있으며, 생리활성 물질인 이소플라본, 올리고당, 펩타이드, 피틴산, 식이섬유, 식물성 스테롤, 페놀 성분, 사포닌 등을 함유하고 있어, 영양학적으로나 한방학적으로 많이 이용되고 있다. 칡의 생리활성으로는 항산화 기능 및 술독 제거, 간 보호 등 간 기능의 저하를 방지하는 효과가 있으며, 해열 작용, 혈압 및 심장박동 강화 작용 등이 알려져 있다. 또한, 골다공증 치료에 효과가 있는 에스트로겐성 물질도 다량 함유되어 있는 것으로 보고되고 있다.칡 ( Pueraria hirsuta Matsum is a leguminosae plant native to Korea and other parts of Southeast Asia. Its root is composed of about 16 ~ 19% of starch, and its physiologically active isoflavones, oligosaccharides, peptides, phytic acid, dietary fiber, It contains plant sterols, phenol components, saponins, etc., and is widely used in nutrition and oriental medicine. The physiological activity of 칡 is effective to prevent deterioration of liver function such as antioxidative function, elimination of digoxin, and liver protection, and it is known that the antipyretic action, the blood pressure and the strengthening action of the heartbeat. It has also been reported that estrogenic substances, which are effective in the treatment of osteoporosis, are also contained in large amounts.
폐경기 이후 여성에서는 에스트로겐의 급속한 감소로 인하여, 심리학적 및 감성적 징후, 예컨대 피로, 흥분, 불면, 집중력 저하, 우울증, 기억 상실, 두통, 근심 및 신경과민이나 소심증 등이 발생할 우려가 현저히 높아지게 되며, 재발성 안면 홍조에 의한 수면 방해에 따른 피로와 흥분, 간헐성 현기증, 감각이상, 심계항진 및 빈맥, 메스꺼움, 변비, 설사, 관절통, 근육통, 수족 냉증 및 체중 증가 현상의 발생 우려 또한 현저히 높아지게 된다. 또한, 골다공증이 쉽게 유발될 뿐 아니라, 심장병, 고혈압, 뇌졸중 등의 심혈관계 질환으로 인한 사망률도 증가한다. 또한, 피부 및 비뇨생식계통의 변화를 초래하며, 자가면역성 질환, 백내장 및 대장암 등의 발병 가능성이 높아지게 된다.In postmenopausal women, the rapid decrease in estrogen significantly increases the likelihood of psychological and emotional symptoms such as fatigue, excitement, insomnia, loss of concentration, depression, amnesia, headache, anxiety and nervousness or asthma, The risk of fatigue and excitement, intermittent dizziness, sensory abnormality, palpitations and tachycardia, nausea, constipation, diarrhea, arthralgia, myalgia, poor circulation and weight gain due to sleep disturbance caused by sex steroid flushing are also significantly increased. In addition, osteoporosis is not only easily induced, but also increases mortality from cardiovascular diseases such as heart disease, hypertension and stroke. It also causes changes in the skin and genitourinary system and increases the likelihood of developing autoimmune diseases, cataracts and colon cancer.
현재, 상기 갱년기 증상을 개선하는데 있어서 가장 효과적인 공지의 방법은 에스트로겐을 투여하여 결핍된 에스트로겐을 보충해 주는 것으로 알려져 있다.Presently, it is known that the most effective known method for improving the above menopausal symptoms is to administer estrogen to supplement deficient estrogen.
그러나, 합성 에스트로겐의 장기간에 걸친 투여는 유방암과 자궁암을 유발할 수 있다는 심각한 문제점이 있다. 최근 들어서는 장기간에 걸친 합성 에스트로겐 대체 요법이 유방암을 유발할 가능성이 높다는 믿을 만한 주장이 다수 제기되면서 학자들 간에는 물론, 사회 전반에 걸쳐 논란이 가열되고 있다. 아직 확실히 증명된 것은 아니지만, 합성 에스트로겐 대체 요법을 받은 여성에 있어서의 유방암 발생 위험은 시간 경과에 따른 에스트로겐 노출 용량과 관련이 있는 것으로 믿어지고 있다.However, there is a serious problem that long-term administration of synthetic estrogen can cause breast cancer and uterine cancer. Recently, a lot of arguments have been made to believe that long-term synthetic estrogen replacement therapy is likely to induce breast cancer, raising controversy among scholars and society as a whole. Although not yet proven, it is believed that the risk of developing breast cancer in women receiving synthetic estrogen replacement therapy is related to their estrogen exposure over time.
따라서, 상기 호르몬 대체 요법에 사용되는 합성 에스트로겐의 보다 안전한 대체물로서 식물성 에스트로겐인 피토에스트로겐을 찾고자 하는 연구가 최근 활발히 진행되고 있는 추세에 있다. 상기 피토에스트로겐은 동물의 체내에서 에스트로겐성 효과를 발휘하는 식물 중에 존재하는 비스테로이드성 화합물을 지칭하며, 항암 작용과 심장병에 효과가 있는 것으로 알려져 있는 곡물, 과일, 채소들의 대부분은 피토에스트로겐을 미량 포함하고 있다.Therefore, there is a recent trend toward research on phytoestrogens, which are phytoestrogens, as safer alternatives to synthetic estrogens used in hormone replacement therapies. The phytoestrogens refer to non-steroidal compounds present in plants that exert an estrogenic effect in the body of an animal. Most of the grains, fruits and vegetables known to have anticancer effects and effects on heart disease contain trace amounts of phytoestrogens .
한국등록특허 제1872344호에는 아미노산이 함유된 더치커피의 제조방법이 개시되어 있고, 한국등록특허 제1865409호에는 더치커피의 제조방법이 개시되어 있으나, 본 발명의 석류 과실과 칡뿌리 추출물을 이용한 여성 갱년기 개선용 기능성 더치커피의 제조방법과는 상이하다.Korean Patent No. 1872344 discloses a process for preparing adult coffee containing amino acids and Korean Patent No. 1865409 discloses a process for producing Dutch coffee. However, in the case of using the pomegranate fruit and pine root extract of the present invention, It is different from the production method of functional Dutch coffee for the improvement of menopausal age.
본 발명은 상기와 같은 요구에 의해 안출된 것으로서, 본 발명의 목적은 더치커피의 유효성분 및 기능성을 향상시키면서 갱년기 증상 개선과 기호도가 우수한 더치커피를 제조하기 위해, 약용식물 종류 선정 및 전처리, 배합비, 더치커피 추출 등의 제조조건을 최적화하여, 폴리페놀 및 플라보노이드를 다량 함유하면서 항산화 활성이 우수하고, 더불어 갱년기 증상 개선의 건강 증진 효과와 기호도가 우수한 새로운 형태의 더치커피의 제조방법을 제공하는 데 있다.SUMMARY OF THE INVENTION The present invention has been made in view of the above-mentioned needs, and an object of the present invention is to provide a method and an apparatus for improving the effective ingredients and functionalities of Dutch coffee, The present invention provides a method of manufacturing a new type of Dutch coffee having an excellent antioxidative activity while containing a large amount of polyphenols and flavonoids, have.
상기 과제를 해결하기 위해, 본 발명은 (a) 물에 L-카르니틴을 혼합하여 알칼리수를 제조하고, 커피 분말을 필터통에 채우고 상기 알칼리수를 부어 더치커피를 추출하는 단계; (b) 백수오와 구절초를 각각 증열 처리하고 그늘에서 건조한 후, 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 첨가한 후 추출하여 백수오 추출액 및 구절초 추출액을 제조하는 단계; (c) 칡과 쇠별꽃을 각각 증열 처리한 후 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 첨가한 후 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하는 단계; (d) 석류를 식초물에 침지한 후 꺼내어 세척하고, 열풍건조하고 파쇄한 석류 분말에 물을 첨가한 후 추출하여 석류 추출액을 제조하는 단계; (e) 상기 (b)단계의 제조한 백수오 추출액, 구절초 추출액, 상기 (c)단계의 제조한 칡 추출액, 쇠별꽃 추출액 및 상기 (d)단계의 제조한 석류 추출액을 혼합한 혼합 추출액을 농축하여 혼합 농축액을 제조하는 단계; 및 (f) 상기 (a)단계의 추출한 더치커피에 상기 (e)단계에서 제조한 혼합 농축액을 첨가하는 단계를 포함하여 제조하는 것을 특징으로 하는 여성 갱년기 개선을 위한 더치커피의 제조방법을 제공한다.(A) mixing L-carnitine with water to produce alkaline water, filling the filter case with a coffee powder, pouring the alkaline water to extract the Dutch coffee; (b) a step of preparing a white water extract and a yellowtail oil extract by adding water to the white powdery white powder and crushed blue powder, respectively, after each of the white powder and the yellow powder is dehydrated and dried in the shade, (c) a step of heat-treating each of the leaves and the calyces, followed by hot-air drying, adding water to the crushed and powdered wheat flour, (d) immersing the pomegranate in vinegar, removing the pomegranate, washing it, adding hot water to the crushed pomegranate powder, and extracting it to prepare a pomegranate extract; (e) The mixed extract obtained by mixing the prepared white water extract, the herb extract, the prepared extract of step (c), the sphagnum extract and the pomegranate extract prepared in step (b) Preparing a mixed concentrate; And (f) adding the mixed concentrate prepared in step (e) to the extracted hot coffee of step (a). .
또한, 본 발명은 상기 방법으로 제조된 여성 갱년기 개선을 위한 더치커피를 제공한다.In addition, the present invention provides a Dutch coffee for female climacteric improvement prepared by the above method.
본 발명의 더치커피는 더치커피의 고유한 맛에 약용식물의 풍미를 조화시켜 기호도가 우수한 더치커피를 제조할 수 있으며, 또한, 페놀 화합물 및 플라보노이드를 다량 함유하면서 항산화 활성이 우수할 뿐만 아니라, 꾸준히 섭취할 경우 여성 갱년기 증상을 효과적으로 개선할 수 있어 국민 건강에 도움이 될 수 있는 더치커피를 제공할 수 있다.The Dutch coffee according to the present invention can prepare a Dutch coffee having excellent taste and taste by harmonizing the flavor of a medicinal plant with the inherent taste of Dutch coffee. In addition, it has excellent antioxidative activity while containing a large amount of a phenol compound and flavonoid, If ingested, women's menopausal symptoms can be effectively improved, which can provide a Dutch coffee that can help the public health.
본 발명의 목적을 달성하기 위하여, 본 발명은 In order to achieve the object of the present invention,
(a) 물에 L-카르니틴을 혼합하여 알칼리수를 제조하고, 커피 분말을 필터통에 채우고 상기 알칼리수를 부어 더치커피를 추출하는 단계;(a) mixing L-carnitine with water to produce alkaline water, filling the filter cake with the filter cake, and pouring the alkaline water to extract the instant coffee;
(b) 백수오와 구절초를 각각 증열 처리하고 그늘에서 건조한 후, 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 첨가한 후 추출하여 백수오 추출액 및 구절초 추출액을 제조하는 단계;(b) a step of preparing a white water extract and a yellowtail oil extract by adding water to the white powdery white powder and crushed blue powder, respectively, after each of the white powder and the yellow powder is dehydrated and dried in the shade,
(c) 칡과 쇠별꽃을 각각 증열 처리한 후 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 첨가한 후 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하는 단계;(c) a step of heat-treating each of the leaves and the calyces, followed by hot-air drying, adding water to the crushed and powdered wheat flour,
(d) 석류를 식초물에 침지한 후 꺼내어 세척하고, 열풍건조하고 파쇄한 석류 분말에 물을 첨가한 후 추출하여 석류 추출액을 제조하는 단계;(d) immersing the pomegranate in vinegar, removing the pomegranate, washing it, adding hot water to the crushed pomegranate powder, and extracting it to prepare a pomegranate extract;
(e) 상기 (b)단계의 제조한 백수오 추출액, 구절초 추출액, 상기 (c)단계의 제조한 칡 추출액, 쇠별꽃 추출액 및 상기 (d)단계의 제조한 석류 추출액을 혼합한 혼합 추출액을 농축하여 혼합 농축액을 제조하는 단계; 및(e) The mixed extract obtained by mixing the prepared white water extract, the herb extract, the prepared extract of step (c), the sphagnum extract and the pomegranate extract prepared in step (b) Preparing a mixed concentrate; And
(f) 상기 (a)단계의 추출한 더치커피에 상기 (e)단계에서 제조한 혼합 농축액을 첨가하는 단계를 포함하여 제조하는 것을 특징으로 하는 여성 갱년기 개선을 위한 더치커피의 제조방법을 제공한다.(f) adding the mixed concentrate prepared in the step (e) to the extracted hot coffee of the step (a). The present invention also provides a method of manufacturing a Dutch coffee for improving female menopausal period.
본 발명의 더치커피의 제조방법에서, 상기 (a)단계의 커피 분말은 바람직하게는 커피를 -50~-80℃에서 3~6일 동안 동결건조한 후 분쇄하여 제조할 수 있으며, 더욱 바람직하게는 커피를 -60~-65℃에서 4~5일 동안 동결건조한 후 분쇄하여 제조할 수 있다. 상기와 같은 조건으로 커피를 동결건조한 후 분쇄하는 것이 커피의 유효성분을 파괴하지 않으면서 씁쓸한 맛이 저감되어 기호도를 증진시킬 수 있었다.In the process for producing the Dutch coffee of the present invention, the coffee powder in the step (a) is preferably prepared by lyophilizing the coffee at -50 to -80 캜 for 3 to 6 days and then pulverizing the coffee powder, Lyophilizing the coffee at -60 to -65 캜 for 4 to 5 days, and then pulverizing it. The lyophilization and pulverization of the coffee under the above conditions did not destroy the effective ingredient of the coffee, so bitter taste was reduced and the preference degree could be improved.
또한, 본 발명의 더치커피의 제조방법에서, 상기 (a)단계의 추출은 바람직하게는 커피 분말 80~120 g을 필터통에 채우고 3~7℃의 알칼리수 400~500 mL를 부어 더치커피를 추출할 수 있으며, 더욱 바람직하게는 커피 분말 100 g을 필터통에 채우고 5℃의 알칼리수 450 mL를 부어 더치커피를 추출할 수 있다. 상기와 같은 조건으로 더치커피를 추출하는 것이 커피의 쓴맛은 저감되고 순하고 부드러운 풍미를 지니는 커피로 추출할 수 있었다.In addition, in the process for producing the Dutch coffee of the present invention, the extraction in the step (a) is preferably carried out by filling 80 to 120 g of the coffee powder into the filter pail and pouring 400 to 500 mL of alkaline water at 3 to 7 DEG C to extract the hot coffee More preferably, the filter cake is filled with 100 g of the coffee powder and 450 mL of alkaline water at 5 DEG C is poured to extract the hot coffee. Extracting the Dutch coffee under the above conditions reduced the bitter taste of the coffee and was able to extract it with a coffee having a mild and gentle flavor.
또한, 본 발명의 더치커피의 제조방법에서, 상기 (a)단계의 알칼리수는 바람직하게는 물에 L-카르니틴을 1~2%(w/v) 혼합하여 제조할 수 있으며, 더욱 바람직하게는 물에 L-카르니틴을 1.5%(w/v) 혼합하여 제조할 수 있다. 상기와 같은 조건으로 제조된 알칼리수를 이용하여 더치커피를 추출하는 것이 추출 효율이 더 높고 커피 고유의 향과 깊은맛을 충분히 우려내어 커피의 풍미를 더욱 향상시킬 수 있었다.In addition, in the process for producing the Dutch coffee of the present invention, the alkaline water in the step (a) may be prepared by mixing 1 to 2% (w / v) of L-carnitine in water, Carnitine in an amount of 1.5% (w / v). Extraction of Dutch coffee using alkaline water produced under the above conditions was more effective in extracting and sufficiently enhancing the flavor and deep taste of the coffee, thereby further improving the flavor of the coffee.
또한, 본 발명의 더치커피의 제조방법에서, 상기 (b)단계는 바람직하게는 백수오와 구절초를 각각 90~100℃에서 1~3분 동안 증열 처리하고 20~25℃에서 4~6시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2~3회 반복한 후, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 12~18배(v/w)씩 첨가한 후 90~95℃에서 10~15시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조할 수 있으며, 더욱 바람직하게는 백수오와 구절초를 각각 100℃에서 2분 동안 증열 처리하고 20~25℃에서 5시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2회 반복한 후, 55℃에서 24시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 15배(v/w)씩 첨가한 후 90~95℃에서 13시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조할 수 있다.In step (b) of the present invention, the step (b) is preferably a step of treating the white pearl and the safflower seeds at 90 to 100 ° C for 1 to 3 minutes and then treating them at 20 to 25 ° C for 4 to 6 hours After shaking for 2 ~ 3 times, the mixture was dried at 50 ~ 60 ℃ for 20 ~ 28 hours. The water was added 12 ~ 18 times (v / w), and then extracted at 90 to 95 ° C for 10 to 15 hours to produce Baekgoo extract and Rhus javanica extract. More preferably, Paekcheo and Rhus japonica are each subjected to a heat treatment at 100 ° C for 2 minutes, After repeatedly heating and drying in shade for 5 hours at ~ 25 ° C, it was dried twice with hot air for 24 hours at 55 ° C, and water was added to the crushed white powder and crushed powder at 15 times (v / w) ), And the mixture was extracted at 90 to 95 ° C for 13 hours. The can be prepared.
또한, 본 발명의 더치커피의 제조방법에서, 상기 (c)단계는 바람직하게는 칡과 쇠별꽃을 각각 90~100℃에서 3~5분 동안 증열 처리한 후 50~60℃에서 32~40시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 12~18배(v/w)씩 첨가한 후 90~95℃에서 6~10시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조할 수 있으며, 더욱 바람직하게는 칡과 쇠별꽃을 각각 100℃에서 4분 동안 증열 처리한 후 55℃에서 36시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 15배(v/w)씩 첨가한 후 90~95℃에서 8시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조할 수 있다.In step (c) of the present invention, the step (c) is preferably a step of heat-treating the bean curd and calamus at 90 to 100 ° C for 3 to 5 minutes and then heating at 50 to 60 ° C for 32 to 40 hours (V / w) of water is added to the dried and crushed 칡 powder and the sphagnum powder, respectively, and then the mixture is extracted at 90 to 95 캜 for 6 to 10 hours to prepare the 칡 extract, More preferably, the pearl bean sprouts and calyces are subjected to a steam treatment at 100 ° C for 4 minutes, followed by hot air drying at 55 ° C for 36 hours, adding 15 times (v / w) water to each of the crushed and powdered wheat flour And then extracted at 90 to 95 ° C for 8 hours to prepare an extract of Lycoris spp.
또한, 본 발명의 더치커피의 제조방법에서, 상기 (d)단계는 바람직하게는 석류를 0.8~1.2%(v/v) 식초물에 8~12분 동안 침지한 후 꺼내어 세척하고, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 석류 분말에 물을 12~18배(v/w)씩 첨가한 후 90~95℃에서 3~5시간 동안 추출하여 석류 추출액을 제조할 수 있으며, 더욱 바람직하게는 석류를 1%(v/v) 식초물에 10분 동안 침지한 후 꺼내어 세척하고, 55℃에서 24시간 동안 열풍건조하고 파쇄한 석류 분말에 물을 15배(v/w)씩 첨가한 후 90~95℃에서 4시간 동안 추출하여 석류 추출액을 제조할 수 있다.In step (d) of the present invention, the step (d) is preferably carried out by immersing the pomegranate in vinegar of 0.8 to 1.2% (v / v) for 8 to 12 minutes, The pomegranate extract can be prepared by adding water 12 to 18 times (v / w) to the crushed pomegranate powder for 20 to 28 hours at 20 to 28 hours and then extracting at 90 to 95 ° C for 3 to 5 hours. More preferably, the pomegranate is immersed in 1% (v / v) vinegar for 10 minutes, washed out, washed with hot air for 24 hours at 55 DEG C, and water is added 15 times (v / w) And then extracted at 90 to 95 ° C for 4 hours to prepare a pomegranate extract.
상기 (b) 내지 (d)단계의 조건으로 재료 전처리 및 추출하여 추출액을 제조하는 것이 유효성분 함량과 항산화 활성이 우수하고, 순하면서 부드러워 음용이 용이하면서 향미가 우수하여 더치커피 혼합에 적합한 약용식물 추출액으로 준비할 수 있었다.The pretreatment and extraction of the material under the conditions of the above steps (b) to (d) to produce the extract have excellent effects on the active ingredient content and antioxidant activity, and are smooth and soft, It was prepared as an extract.
또한, 본 발명의 더치커피의 제조방법에서, 상기 (e)단계의 혼합 추출액은 바람직하게는 혼합 추출액 총 부피 기준으로, 백수오 추출액 16~24 부피%, 구절초 추출액 8~12 부피%, 칡 추출액 25~35 부피%, 쇠별꽃 추출액 8~12 부피% 및 석류 추출액 25~35 부피%를 혼합하여 제조할 수 있으며, 더욱 바람직하게는 혼합 추출액 총 부피 기준으로, 백수오 추출액 20 부피%, 구절초 추출액 10 부피%, 칡 추출액 30 부피%, 쇠별꽃 추출액 10 부피% 및 석류 추출액 30 부피%를 혼합하여 제조할 수 있다. 상기와 같은 재료 및 배합비로 혼합된 혼합 추출액은 총 페놀 및 플라보노이드 함량이 높고 항산화 활성이 증진될 뿐만 아니라, 갱년기 개선에 더욱 효과를 나타내면서 기호도가 우수한 더치커피 제조에 적합한 혼합 추출액으로 준비할 수 있었다.In addition, in the process for producing Dutch coffee according to the present invention, the mixed extract of step (e) preferably contains 16 to 24% by volume of Baekgoo extract, 8 to 12% by volume of Rhus japonica extract, 25 to 35% by volume of the extract of Aspergillus oryzae, 8 to 12% by volume of the extract of calyptium and 25 to 35% by volume of the extract of the pomegranate. More preferably, 20% 30% by volume of the extract, 30% by volume of the extract of the pomegranates, 10% by volume of the extract of the kernels, and 30% by volume of the extract of the pomegranate. The mixed extracts mixed with the above materials and the mixing ratios could be prepared as a mixed extract suitable for the production of Dutch coffee having high total phenol and flavonoid content and antioxidative activity,
또한, 본 발명의 더치커피의 제조방법에서, 상기 (f)단계는 바람직하게는 더치커피에 혼합 농축액을 0.3~0.5 부피% 첨가할 수 있으며, 더욱 바람직하게는 더치커피에 혼합 농축액을 0.4 부피% 첨가할 수 있다. 상기와 같은 비율로 혼합하는 것이 더치커피와 혼합 농축액의 맛과 향이 잘 어우러지고, 쓴맛은 저감되어 기호도가 우수한 커피로 제조할 수 있었다.Further, in the method for producing the Dutch coffee of the present invention, the step (f) may preferably add 0.3 to 0.5% by volume of the mixed concentrate to the Dutch coffee, more preferably the mixed concentrate to 0.4% Can be added. Mixing in the same ratio as above resulted in a good taste and flavor of the Dutch coffee and the mixed concentrate, and the bitter taste was reduced, so that the coffee could be produced with excellent taste.
본 발명의 더치커피의 제조방법은, 보다 구체적으로는The method for producing the Dutch coffee according to the present invention, more specifically,
(a) 물에 L-카르니틴을 1~2%(w/v) 혼합하여 알칼리수를 제조하고, 커피 분말을 필터통에 채우고 상기 알칼리수를 부어 더치커피를 추출하는 단계;(a) mixing alkaline water by mixing 1 to 2% (w / v) of L-carnitine in water, filling the filter case with the coffee powder, pouring the alkaline water to extract the instant coffee;
(b) 백수오와 구절초를 각각 90~100℃에서 1~3분 동안 증열 처리하고 20~25℃에서 4~6시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2~3회 반복한 후, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 12~18배(v/w)씩 첨가한 후 90~95℃에서 10~15시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조하는 단계;(b) repeating the process of steam-drying at 90 to 100 ° C for 1 to 3 minutes and drying at 20 to 25 ° C for 4 to 6 hours in shade for 2-3 times, Dried at 50 to 60 ° C for 20 to 28 hours and 12 to 18 times (v / w) of water were added to the crushed white powder and crushed red powder, respectively, followed by extraction at 90 to 95 ° C for 10 to 15 hours Preparing an extract of Bacillus subtilis and an extract of Bacillus subtilis;
(c) 칡과 쇠별꽃을 각각 90~100℃에서 3~5분 동안 증열 처리한 후 50~60℃에서 32~40시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 12~18배(v/w)씩 첨가한 후 90~95℃에서 6~10시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하는 단계;(c) Steatite and calyptium were heated at 90 ~ 100 ℃ for 3 ~ 5 minutes and then hot air dried at 50 ~ 60 ℃ for 32 ~ 40 hours. Water was added 12 ~ 18 times (v / w), followed by extraction at 90 to 95 ° C for 6 to 10 hours to prepare an extract and a sphagnum ganoderma extract;
(d) 석류를 0.8~1.2%(v/v) 식초물에 8~12분 동안 침지한 후 꺼내어 세척하고, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 석류 분말에 물을 12~18배(v/w)씩 첨가한 후 90~95℃에서 3~5시간 동안 추출하여 석류 추출액을 제조하는 단계;(d) Pomegranate is immersed in vinegar of 0.8-1.2% (v / v) for 8-12 minutes, washed out, washed with hot air at 50 ~ 60 ℃ for 20 ~ 28 hours, To 18 times (v / w), followed by extraction at 90 to 95 ° C for 3 to 5 hours to prepare a pomegranate extract;
(e) 혼합 추출액 총 부피 기준으로, 상기 (b)단계의 제조한 백수오 추출액 16~24 부피%, 구절초 추출액 8~12 부피%, 상기 (c)단계의 제조한 칡 추출액 25~35 부피%, 쇠별꽃 추출액 8~12 부피% 및 상기 (d)단계의 제조한 석류 추출액 25~35 부피%를 혼합한 혼합 추출액을 6~8 brix가 되도록 농축하여 혼합 농축액을 제조하는 단계; 및(e) 16 to 24% by volume of the white water extract, 8 to 12% by volume of the Rhus japonica extract, 25 to 35% by volume of the extract of step (c) prepared in the step (b) , 8 to 12 vol.% Of the extract of calyx, and 25 to 35 vol.% Of the pomegranate extract prepared in step (d), to a concentration of 6 to 8 brix to prepare a mixed concentrate; And
(f) 상기 (a)단계의 추출한 더치커피에 상기 (e)단계에서 제조한 혼합 농축액을 0.3~0.5 부피% 첨가하는 단계를 포함할 수 있으며,(f) adding 0.3 to 0.5% by volume of the mixed concentrate prepared in step (e) to the extracted hot coffee of step (a)
더욱 구체적으로는More specifically,
(a) 물에 L-카르니틴을 1.5%(w/v) 혼합하여 알칼리수를 제조하고, 커피 분말을 필터통에 채우고 상기 알칼리수를 부어 더치커피를 추출하는 단계;(a) mixing alkaline water with 1.5% (w / v) of L-carnitine in water to fill the filter pail with the coffee powder, pouring the alkaline water to extract the coffee;
(b) 백수오와 구절초를 각각 100℃에서 2분 동안 증열 처리하고 20~25℃에서 5시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2회 반복한 후, 55℃에서 24시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 15배(v/w)씩 첨가한 후 90~95℃에서 13시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조하는 단계;(b) Repeating the process of heat treatment at 100 ° C. for 2 minutes and drying the shade at 20 ° to 25 ° C. for 2 hours, respectively, and repeating the process of heating and drying twice at 55 ° C. for 24 hours, And adding 15 times (v / w) of water to each of the crushed white pearl powder and the citron powder, and then extracting the mixture at 90 to 95 ° C for 13 hours to prepare white pear extract and Rhizobium extract.
(c) 칡과 쇠별꽃을 각각 100℃에서 4분 동안 증열 처리한 후 55℃에서 36시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 15배(v/w)씩 첨가한 후 90~95℃에서 8시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하는 단계;(c) After heat treatment at 100 ° C for 4 minutes and then hot-air drying at 55 ° C for 36 hours, water was added 15 times (v / w) to each of the crushed and sown flour, To 95 < 0 > C for 8 hours to prepare an extract and an extract of Safflower grisea;
(d) 석류를 1%(v/v) 식초물에 10분 동안 침지한 후 꺼내어 세척하고, 55℃에서 24시간 동안 열풍건조하고 파쇄한 석류 분말에 물을 15배(v/w)씩 첨가한 후 90~95℃에서 4시간 동안 추출하여 석류 추출액을 제조하는 단계;(d) Pomegranate was immersed in 1% (v / v) vinegar for 10 minutes, washed out, washed with hot air for 24 hours at 55 ° C, and water was added 15 times (v / w) to the crushed pomegranate powder Followed by extraction at 90 to 95 ° C for 4 hours to prepare a pomegranate extract;
(e) 혼합 추출액 총 부피 기준으로, 상기 (b)단계의 제조한 백수오 추출액 20 부피%, 구절초 추출액 10 부피%, 상기 (c)단계의 제조한 칡 추출액 30 부피%, 쇠별꽃 추출액 10 부피% 및 상기 (d)단계의 제조한 석류 추출액 30 부피%를 혼합한 혼합 추출액을 7 brix가 되도록 농축하여 혼합 농축액을 제조하는 단계; 및(e) 20% by volume of the extract obtained from step (b), 10% by volume of the extract obtained from step (b), 30% by volume of the extract of step (c) And 30% by volume of the pomegranate extract prepared in the step (d), to a concentration of 7 brix to prepare a mixed concentrate; And
(f) 상기 (a)단계의 추출한 더치커피에 상기 (e)단계에서 제조한 혼합 농축액을 0.4 부피% 첨가하는 단계를 포함할 수 있다.(f) adding 0.4% by volume of the mixed concentrate prepared in step (e) to the extracted hot coffee of step (a).
본 발명은 또한, 상기 방법으로 제조된 더치커피를 제공한다.The present invention also provides a Dutch coffee prepared by the above method.
이하, 본 발명의 제조예 및 실시예를 들어 상세히 설명한다. 단, 하기 제조예 및 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 제조예 및 실시예에 한정되는 것은 아니다.Hereinafter, production examples and examples of the present invention will be described in detail. However, the following Preparation Examples and Examples are illustrative of the present invention, and the content of the present invention is not limited to the following Production Examples and Examples.
제조예Manufacturing example 1. One. 더치커피Dutch coffee 제조 Produce
(a) 정제수에 L-카르니틴(L-Carnitine) 1.5% 첨가한 후 혼합하여 pH 8~8.3 정도의 알칼리성 정제수를 제조하였다.(a) 1.5% of L-Carnitine was added to purified water and then mixed to prepare an alkaline purified water having a pH of 8 to 8.3.
(b) 커피 원두 분말 100 g을 필터통에 채우고 상기 (a)단계의 제조한 5℃의 알칼리성 정제수 100 mL를 붓고 20분간 뜸을 들이고, 다시 알칼리성 정제수 50 mL를 붓고 30분간 뜸을 들인 후, 알칼리성 정제수 300 mL를 부어 필터통 하부의 커피원액 통에 한 방울씩 떨어뜨려 4~6시간 동안 300 mL의 더치커피를 얻었다.(b) 100 g of the coffee bean powder was filled in a filter case, and 100 mL of the alkaline purified water prepared in the step (a) was poured and poured for 20 minutes. Then, 50 mL of alkaline purified water was poured, 300 mL of alkaline purified water was poured and dropped one drop into the coffee liquor bottle under the filter case to obtain 300 mL Dutch coffee for 4 to 6 hours.
(c) 0.5 cm 정도의 두께로 편절한 백수오와 구절초를 각각 100℃에서 2분 동안 증열처리한 후 20~25℃에서 5시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2회 반복한 후, 55℃에서 24시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 정제수를 각각 15배(v/w)씩 첨가하여 90~95℃에서 13시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조하였다.(c) After heating for two minutes at 100 ° C and then heating at 20 ° C to 25 ° C for 5 hours, shaking and drying were repeated twice. (V / w) was added to each of the crushed white powder and the crushed basal powder at 55 ° C for 24 hours, and the mixture was extracted at 90 to 95 ° C for 13 hours. Respectively.
(d) 0.5 cm 정도의 두께로 편절한 칡과 쇠별꽃을 각각 100℃에서 4분 동안 증열처리한 후 55℃에서 36시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 정제수를 각각 15배(v/w)씩 첨가하여 90~95℃에서 8시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하였다.(d) A 0.5 cm-thick brown bean curd and calyptium were heated for 4 minutes at 100 ° C for 4 minutes, then hot-air dried at 55 ° C for 36 hours, / w), and the mixture was extracted at 90 to 95 ° C for 8 hours to prepare an extract and a flower extract.
(e) 석류를 1% 식초물에 10분 동안 침지한 후 꺼내어 세척하고, 0.5 cm 정도의 두께로 세절한 후 55℃에서 24시간 동안 열풍건조하고 파쇄한 석류 분말에 정제수를 15배(v/w) 첨가하여 90~95℃에서 4시간 동안 추출하여 석류 추출액을 제조하였다.(e) pomegranate was immersed in 1% vinegar for 10 minutes, washed out, cut into 0.5 cm thickness, hot-air dried at 55 ° C for 24 hours, poured into pomegranate powder 15 times (v / w), and extracted at 90 to 95 ° C for 4 hours to prepare a pomegranate extract.
(f) 혼합 추출액 총 부피 기준으로, 상기 (c)단계의 제조한 백수오 추출액 20 부피%, 구절초 추출액 10 부피%, 상기 (d)단계의 제조한 칡 추출액 30 부피%, 쇠별꽃 추출액 10 부피% 및 상기 (e)단계의 제조한 석류 추출액 30 부피%를 혼합한 후 7 brix가 되도록 감압하에서 농축하여 혼합 농축액을 제조하였다.(f) 20% by volume of the extract obtained from step (c), 10% by volume of the extract of Rhus japonica, 30% by volume of the extract of step (d) prepared above, 10% And 30% by volume of the pomegranate extract prepared in the step (e), and then concentrated under reduced pressure to a brix of 7 brix to prepare a mixed concentrate.
(g) 상기 (b)단계의 제조한 더치커피에 상기 (f)단계에서 제조한 허브 농축액을 0.4부피% 첨가하여 기능성 더치커피를 제조하였다.(g) Functional Dutch coffee was prepared by adding 0.4% by volume of the herbal concentrate prepared in the step (f) to the Dutch coffee prepared in the step (b).
비교예Comparative Example 1: One: 더치커피Dutch coffee 제조 Produce
커피 분말 100 g을 필터통에 채우고 5℃의 정제수 100 mL를 붓고 20분간 뜸을 들이고, 다시 정제수 50 mL를 붓고 30분간 뜸을 들인 후, 정제수 300 mL를 부어 필터통 하부의 커피원액 통에 한 방울씩 떨어뜨려 4~6시간 동안 300 mL의 더치커피를 얻었다.100 g of the coffee powder is poured into the filter pail, and 100 mL of purified water at 5 ° C is poured in, and the solution is poured for 20 minutes. Pour 50 mL of purified water again and boil for 30 minutes. Pour 300 mL of purified water into the coffee pail The drop was dropped to obtain 300 mL Dutch coffee for 4 to 6 hours.
비교예Comparative Example 2 내지 4. 2 to 4. 더치커피Dutch coffee 제조 Produce
상기 제조예 1의 방법으로 더치커피를 제조하되, 상기 (f)단계에서 혼합 추출액 제조 시 추출액의 배합비를 상기 표 1과 같이 배합한 혼합 추출액을 이용하여 더치커피를 제조하였다.Dutch coffee was prepared by the method of Preparation Example 1, and in the step (f), a mixture of extracts was prepared in the same manner as in Table 1 to prepare Dutch coffee.
비교예Comparative Example 5. 5. 더치커피Dutch coffee 제조 Produce
상기 제조예 1의 방법으로 더치커피를 제조하되, (c) 내지 (e)단계의 백수오 추출액, 구절초 추출액, 칡 추출액, 쇠별꽃 추출액 및 석류 추출액 제조 시 하기와 같은 조건으로 처리한 추출액을 가지고 더치커피를 제조하였다.A method for preparing Dutch coffee according to the method of Preparation Example 1, wherein an extract obtained from the steps (c) to (e) is subjected to the following conditions in the preparation of white water extract, Rhizoma extract, Coffee.
(c) 0.5 cm 정도의 두께로 편절한 백수오와 구절초를 각각 100℃에서 4분 동안 증열처리한 후 20~25℃에서 10시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2회 반복한 후, 45℃에서 18시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 정제수를 각각 15배(v/w)씩 첨가하여 90~95℃에서 8시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조하였다.(c) 0.5 degree heat-treatment at 100 ℃ for 4 minutes, followed by shaking for 10 hours at 20 ~ 25 ℃. (V / w) was added to each of the crushed white powder and the crushed red powder at 45 ° C. for 18 hours, followed by extraction at 90 ° C. to 95 ° C. for 8 hours. Respectively.
(d) 0.5 cm 정도의 두께로 편절한 칡과 쇠별꽃을 각각 100℃에서 2분 동안 증열처리한 후 70℃에서 24시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 정제수를 각각 15배(v/w)씩 첨가하여 90~95℃에서 13시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하였다.(d) A 0.5 cm-thick brown bean curd and calyptium were heated for 2 minutes at 100 ° C for 2 minutes, then hot-air dried for 24 hours at 70 ° C, and 15 times (v / w), and the mixture was extracted at 90 to 95 ° C for 13 hours to prepare an extract of Lycoris spp.
(e) 석류를 1% 식초물에 20분 동안 침지한 후 꺼내어 세척하고, 0.5 cm 정도의 두께로 세절한 후 55℃에서 36시간 동안 열풍건조하고 파쇄한 석류 분말에 정제수를 15배(v/w) 첨가하여 90~95℃에서 8시간 동안 추출하여 석류 추출액을 제조하였다.(e) Pomegranate was immersed in 1% vinegar for 20 minutes, washed out, cut into 0.5 cm thickness, hot-air dried at 55 ° C for 36 hours, and poured into pomegranate powder 15 times (v / w), and extracted at 90 to 95 ° C for 8 hours to prepare a pomegranate extract.
실시예Example 1: 총 페놀화합물 함량 측정 1: Determination of total phenolic compound content
총 페놀화합물 함량은 폴린-데니스(Folin-Denis) 방법에 따라 분석하였다. 시료를 1 ㎎/㎖로 조제한 후, 이 시료액 1 ㎖에 증류수 3 ㎖를 넣고 Folin & Ciocalteu's 페놀 시약 1 ㎖를 첨가한 후 27℃ 쉐이킹배스(shaking bath)에서 혼합하였다. 5분 후 NaCO3 포화용액 1 ㎖를 넣고 혼합하여 실온에서 1시간 방치한 후 640 nm에서 분광광도계(UV-1650PC, SHIMADZU)로 흡광도를 측정하였다. 페놀화합물 함량은 카테킨(catechin), 탄닌산(tannic acid), 클로로겐산(chlorogenic acid)의 농도를 이용하여 검량선을 작성한 다음 정량하였다.The total phenolic compound content was analyzed according to the Folin-Denis method. After adjusting the sample to 1 mg / ml, 3 ml of distilled water was added to 1 ml of the sample solution, 1 ml of Folin &Ciocalteu's phenol reagent was added, and the mixture was mixed at 27 ° C in a shaking bath. After 5 minutes, 1 ml of NaCO 3 saturated solution was added, and the mixture was allowed to stand at room temperature for 1 hour. Then, the absorbance was measured with a spectrophotometer (UV-1650PC, SHIMADZU) at 640 nm. The contents of phenolic compounds were determined by using calibration curves of catechin, tannic acid and chlorogenic acid.
비교예들과 제조예 1의 방법으로 제조된 더치커피의 총 페놀화합물 함량은 표 2에 나타내었다. 표 2에서 알 수 있는 바와 같이, 클로로겐산 기준으로, 혼합 추출액을 첨가하지 않은 비교예 1의 더치커피가 가장 낮은 함량을 나타내었고, 제조예 1의 더치커피가 클로로겐산 함량 기준으로 다른 비교예들에 비해 가장 높은 페놀 함량을 나타내었고, 카테킨 및 탄닌도 동일한 결과를 나타내었다.The total phenolic compound contents of Dutch coffee prepared by the comparative examples and the method of Preparation Example 1 are shown in Table 2. As can be seen from Table 2, the Dutch coffee of Comparative Example 1, on which the mixed extract was not added, showed the lowest content on the basis of the chlorogenic acid, and the Dutch coffee of Preparation Example 1 was comparable to the other Comparative Examples on the basis of the content of chlorogenic acid The highest phenol contents were obtained and catechin and tannin showed the same results.
실시예Example 2: 총 플라보노이드 함량 측정 2: Total flavonoid content measurement
커피의 총 플라보노이드 함량 측정은 제조한 각각의 커피를 증류수로 희석하여 분석용 시료로 제조한 다음 이 검액 1.0 ㎖를 시험관에 취하고 10 ㎖의 디에틸렌 글리콜(diethylen glycol)을 가하여 잘 혼합하였다. 다시 여기에 1N NaOH 0.1 ㎖를 잘 혼합시켜 37℃의 항온수조(water bath)에서 1시간 동안 반응시킨 후 420 nm에서 흡광도를 측정하였다. 공시험은 시료 용액 대신 증류수를 동일하게 처리하였으며, 표준곡선은 나린진(Sigma co., USA)을 이용하여 작성하고 이로부터 총 플라보노이드 함량을 구하였다.To measure the total flavonoid content of coffee, each coffee was diluted with distilled water to prepare an analytical sample. Then, 1.0 ml of the test liquid was placed in a test tube, and 10 ml of diethylen glycol was added thereto. Again, 0.1 ml of 1N NaOH was mixed well and reacted in a constant temperature water bath at 37 ° C for 1 hour and the absorbance at 420 nm was measured. Blank test was performed by treating distilled water instead of sample solution, and standard curve was prepared using NARINJIN (Sigma co., USA), and the total flavonoid content was determined from this.
비교예들과 제조예 1의 방법으로 제조된 더치커피의 총 플라보노이드 함량을 상기 표 3에 나타내었다. 표 3에서 알 수 있는 바와 같이, 제조예 1의 더치커피가 가장 높은 함량을 보였고, 비교예 1의 더치커피가 가장 낮게 함유한 것으로 나타났다.The total flavonoid contents of Dutch coffee prepared by the methods of Comparative Examples and Production Example 1 are shown in Table 3 above. As can be seen from Table 3, the Dutch coffee of Preparation Example 1 showed the highest content and the Dutch coffee of Comparative Example 1 contained the lowest content.
실시예Example 3: 3: DPPHDPPH 라디칼Radical 소거능Scatters 시험 exam
커피의 추출물을 수소전자공여능에 의해 항산화 활성을 측정하기 위해 제조예 1과 비교예들의 시료를 증류수로 희석하여, 900 ㎕의 DPPH 용액(100 uM)과 각 시료 100 ㎕를 혼합하여 교반하였다. 이 혼합 시료를 암소에서 30분간 반응시킨 후 517 nm에서 흡광도를 측정하였다. 수소전자공여능은 각 실험을 3회 반복하여 평균을 낸 다음 대조구에 대한 흡광도의 감소 정도를 다음 식에 의하여 계산하였다.In order to measure the antioxidative activity of the extract of coffee by hydrogen electron donating ability, samples of Preparation Example 1 and Comparative Examples were diluted with distilled water, and 900 μl of DPPH solution (100 μM) and 100 μl of each sample were mixed and stirred. This mixture was reacted in a dark place for 30 minutes and absorbance was measured at 517 nm. The hydrogen electron donating ability was evaluated by repeating each experiment three times and then calculating the degree of decrease in absorbance of the control by the following equation.
An = (A0-A)/A0 × 100An = (A 0 -A) / A 0 100
An: DPPH 라디칼 소거능에 대한 항산화 활성(%)An: Antioxidant activity against DPPH radical scavenging activity (%)
A0: 시료가 첨가되지 않은 DPPH 용액의 흡광도A 0 : Absorbance of DPPH solution without added sample
A: 반응용액 중의 DPPH와 시료의 반응한 흡광도A: The absorbance of DPPH in the reaction solution and the absorbance of the sample
비교예들과 제조예 1의 방법으로 제조된 더치커피의 DPPH 라디칼 소거능 결과는 상기 표 4에 나타내었다. 표 4에서 알 수 있는 바와 같이, 제조예 1의 더치커피의 항산화 활성이 68.3%로 가장 높게 나타났다. 50% DPPH 라디칼 소거능을 보이는 데 필요한 추출물량, 즉 IC50값은 역시 제조예 1이 가장 낮게 나타나 앞의 결과와 일치한 것으로 나타났다.DPPH radical scavenging activity of Dutch coffee prepared by the comparative examples and the method of Preparation Example 1 is shown in Table 4 above. As can be seen from Table 4, the antioxidant activity of Dutch coffee of Preparation Example 1 was the highest at 68.3%. The amount of the extract required to exhibit the 50% DPPH radical scavenging ability, that is, the IC 50 value, was also lowest in Preparation Example 1, which was consistent with the foregoing results.
실시예Example 4: 아질산염 4: nitrite 소거능Scatters 시험 exam
커피의 아질산염 소거작용의 측정은 1mM NaNO2 20 ㎕에 시료의 추출액 40 ㎕와 0.1N HCl(pH 1.2) 또는 0.2M 시트레이트 버퍼(citrate buffer, pH 4.2) 또는 0.2M 시트레이트 버퍼(citrate buffer, pH 6.0)를 140 ㎕ 사용하여 부피를 200 ㎕로 맞추었다. 이 반응액을 37℃ 항온수조에서 1시간 반응시킨 후 2% 아세트산(acetic acid) 1,000 ㎕, 그리스(Griess) 시약(30% 아세트산으로 조제한 1% 설파닐산(sulfanilic acid)과 1% 나프틸아민(naphthylamine)을 1:1 비율로 혼합한 것, 사용 직전에 조제) 80 ㎕를 가하여 잘 혼합시켜 빛을 차단한 상온에서 15분간 반응시킨 후 520 nm에서 흡광도를 측정하여 아래와 같은 식을 이용하여 아질산염 소거능을 구하였다.To measure the nitrite scavenging effect of coffee, 40 μl of sample extract and 0.1 N HCl (pH 1.2) or 0.2 M citrate buffer (pH 4.2) or 0.2 M citrate buffer were added to 20 μl of 1 mM NaNO 2 , pH 6.0) was adjusted to a volume of 200 mu l. The reaction solution was reacted in a constant temperature water bath at 37 ° C for 1 hour, and then 1,000 μl of 2% acetic acid and 1 μl of a Griess reagent (1% sulfanilic acid and 1% naphthylamine (30% naphthylamine) in a ratio of 1: 1, prepared immediately before use) was added and mixed well. The mixture was incubated at room temperature for 15 minutes at room temperature. Absorbance was measured at 520 nm, Respectively.
N(%) = [1-(A-C)/B]×100N (%) = [1- (A-C) / B] 100
N: 아질산염 소거능N: Nitrite scavenging ability
A: 1mM NaNO2에 샘플 첨가 1시간 후 흡광도A: After 1 hour of addition of the sample to 1 mM NaNO 2 absorbance
B: 1mM NaNO2 흡광도B: 1 mM NaNO 2 Absorbance
C: 대조구 흡광도C: Control absorbance
비교예들과 제조예 1의 방법으로 제조된 더치커피의 아질산염 소거능 결과는 상기 표 5에 나타내었다. 표 5에서 알 수 있는 바와 같이, 제조예 1의 더치커피의 아질산염 소거능이 60.1%로 가장 높게 나타났고 비교예 1의 혼합 추출액을 첨가하지 않은 더치커피가 가장 낮은 아질산염 소거능을 보였다.The nitrite scavenging activity of Dutch coffee prepared by the comparative examples and the method of Preparation Example 1 is shown in Table 5 above. As can be seen in Table 5, the nitrite scavenging ability of the Dutch coffee of Preparation Example 1 was the highest at 60.1%, and the Dutch coffee without the mixed extract of Comparative Example 1 showed the lowest nitrite scavenging ability.
실시예Example 5: 갱년기 증상 개선효과 확인 5: Checking the effect of improving the symptoms of menopause
갱년기 증상을 나타내는 40~65세의 여성 60명을 각 6개의 군으로 나누어, 상기 제조예 1과 비교예들의 더치커피를 각각 1일 2회 200 mL를 복용하게 하였고, 30일 복용한 후 주요 갱년기 증상에 대한 개선 정도를 10점 척도법으로 평가하게 하였다.Sixty women aged 40 to 65 years who showed symptoms of menopausal symptoms were divided into 6 groups, and 200 mL of the Dutch coffee of Preparation Example 1 and Comparative Example were administered twice a day, respectively. After 30 days of administration, The degree of symptom improvement was evaluated by a 10 - point scale.
주요 갱년기 증상인 안면홍조, 다한증, 오한증, 피로감, 우울감, 수면장애 및 불안감의 7가지 항목에 대한 개선 정도를 평가한 결과, 모든 항목에서 제조예 1의 더치커피를 섭취한 갱년기 증상을 가진 여성이 8~9점대의 갱년기 증상 개선 효과를 보인 반면, 비교예들은 7점 이하의 점수를 보여, 제조예 1의 더치커피가 여성 갱년기 증상 개선 효과가 우수함을 확인할 수 있었다.As a result of evaluating the degree of improvement in seven items of major menopausal symptoms such as facial flushing, hyperhidrosis, sweating, tiredness, depression, sleeping disorder and anxiety, women with menopausal symptoms 8 to 9 points of the menopausal symptom improvement effect, whereas the comparative examples showed scores of 7 points or less. Thus, it was confirmed that the Dutch coffee of Preparation Example 1 is excellent in improving the female menopausal symptom.
실시예Example 6: 6: 더치커피의Dutch coffee 관능검사 Sensory test
청소년 20명(14~18세, 남녀 10명씩), 여성(19~64세) 30명, 남성(19~64세) 30명, 65세 이상 여성 10명, 65세 이상 남성 10명, 총 100명을 대상으로 제조예 1 및 비교예들의 더치커피를 시음하게 하고 냄새, 맛, 쓴맛 및 종합 기호도 평가를 실시하여, 5점 척도법(1점: 매우 나쁨, 2점: 나쁨, 3점: 보통, 4점: 좋음, 5점: 매우 좋음)으로 점수를 매겨 그 결과를 표 7에 나타내었다. 쓴맛에 대한 기호도는 쓴맛의 정도에 따라 1점: 쓴맛이 거의 없음, 3점: 쓴맛이 보통, 5점: 쓴맛이 강함으로 평가하였다.30 men, 19 women and 64 men, 30 women, 10 women aged 65 and over, 10 men aged 65 and over, total of 100 people, 20 people (14 ~ 18 years old, 10 men and 10 women) (1 point: very poor, 2 points: poor, 3 points: normal, and 3 points) were evaluated by subjecting Dutch coffee of Preparation Example 1 and Comparative Example to tasting and evaluating odor, taste, bitter taste, 4 points: good, 5 points: very good). The results are shown in Table 7. The degree of bitterness was evaluated according to bitter taste: 1 point: little bitter taste, 3 points: bitter taste, 5 points: bitter taste.
표 7에서 알 수 있는 바와 같이, 제조예 1의 더치커피가 쓴맛이 약하면서, 다른 비교예들의 더치커피에 비해 냄새, 맛 및 종합 기호도에서 평가자들에 의해 더 선호되는 것을 확인할 수 있었다.As can be seen in Table 7, it was confirmed that the Dutch coffee of Preparation Example 1 was weaker in bitter taste and was preferred by the evaluators in odor, taste and overall preference than the Dutch coffee of the other comparative examples.
이상에서 본 발명의 제조예 및 실시예가 제시되어 있지만 본 발명이 상기에 한정되는 것은 아니며 본 발명의 기술 사상 범위 내에서 다양하게 변형 가능하고 이러한 변형은 하기한 본 발명의 청구범위에 속한다 할 것이다.While the present invention has been particularly shown and described with reference to exemplary embodiments thereof, it is to be understood that the invention is not limited to the disclosed exemplary embodiments, but, on the contrary, is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims.
Claims (5)
(b) 백수오와 구절초를 각각 증열 처리하고 그늘에서 건조한 후, 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 첨가한 후 추출하여 백수오 추출액 및 구절초 추출액을 제조하는 단계;
(c) 칡과 쇠별꽃을 각각 증열 처리한 후 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 첨가한 후 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하는 단계;
(d) 석류를 식초물에 침지한 후 꺼내어 세척하고, 열풍건조하고 파쇄한 석류 분말에 물을 첨가한 후 추출하여 석류 추출액을 제조하는 단계;
(e) 혼합 추출액 총 부피 기준으로, 상기 (b)단계의 제조한 백수오 추출액 16~24 부피%, 구절초 추출액 8~12 부피%, 상기 (c)단계의 제조한 칡 추출액 25~35 부피%, 쇠별꽃 추출액 8~12 부피% 및 상기 (d)단계의 제조한 석류 추출액 25~35 부피%를 혼합한 혼합 추출액을 농축하여 혼합 농축액을 제조하는 단계; 및
(f) 상기 (a)단계의 추출한 더치커피에 상기 (e)단계에서 제조한 혼합 농축액을 첨가하는 단계를 포함하여 제조하는 것을 특징으로 하는 여성 갱년기 개선을 위한 더치커피의 제조방법.(a) mixing L-carnitine with water to produce alkaline water, filling the filter cake with the filter cake, and pouring the alkaline water to extract the instant coffee;
(b) a step of preparing a white water extract and a yellowtail oil extract by adding water to the white powdery white powder and crushed blue powder, respectively, after each of the white powder and the yellow powder is dehydrated and dried in the shade,
(c) a step of heat-treating each of the leaves and the calyces, followed by hot-air drying, adding water to the crushed and powdered wheat flour,
(d) immersing the pomegranate in vinegar, removing the pomegranate, washing it, adding hot water to the crushed pomegranate powder, and extracting it to prepare a pomegranate extract;
(e) 16 to 24% by volume of the white water extract, 8 to 12% by volume of the Rhus japonica extract, 25 to 35% by volume of the extract of step (c) prepared in the step (b) , 8 to 12 vol.% Of the extract of calyx, and 25 to 35 vol.% Of the pomegranate extract prepared in the step (d), and concentrating the mixture to prepare a mixed concentrate; And
(f) adding the mixed concentrate prepared in step (e) to the extracted hot coffee of step (a).
(a) 물에 L-카르니틴을 혼합하여 알칼리수를 제조하고, 커피 분말을 필터통에 채우고 상기 알칼리수를 부어 더치커피를 추출하는 단계;
(b) 백수오와 구절초를 각각 90~100℃에서 1~3분 동안 증열 처리하고 20~25℃에서 4~6시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2~3회 반복한 후, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 첨가한 후 90~95℃에서 10~15시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조하는 단계;
(c) 칡과 쇠별꽃을 각각 90~100℃에서 3~5분 동안 증열 처리한 후 50~60℃에서 32~40시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 첨가한 후 90~95℃에서 6~10시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하는 단계;
(d) 석류를 식초물에 침지한 후 꺼내어 세척하고, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 석류 분말에 물을 첨가한 후 90~95℃에서 3~5시간 동안 추출하여 석류 추출액을 제조하는 단계;
(e) 혼합 추출액 총 부피 기준으로, 상기 (b)단계의 제조한 백수오 추출액 16~24 부피%, 구절초 추출액 8~12 부피%, 상기 (c)단계의 제조한 칡 추출액 25~35 부피%, 쇠별꽃 추출액 8~12 부피% 및 상기 (d)단계의 제조한 석류 추출액 25~35 부피%를 혼합한 혼합 추출액을 농축하여 혼합 농축액을 제조하는 단계; 및
(f) 상기 (a)단계의 추출한 더치커피에 상기 (e)단계에서 제조한 혼합 농축액을 0.3~0.5 부피% 첨가하는 단계를 포함하여 제조하는 것을 특징으로 하는 여성 갱년기 개선을 위한 더치커피의 제조방법.The method according to claim 1,
(a) mixing L-carnitine with water to produce alkaline water, filling the filter cake with the filter cake, and pouring the alkaline water to extract the instant coffee;
(b) repeating the process of steam-drying at 90 to 100 ° C for 1 to 3 minutes and drying at 20 to 25 ° C for 4 to 6 hours in shade for 2-3 times, Drying at 50 to 60 ° C for 20 to 28 hours, adding water to each of the crushed white powder and crushed red powder, and then extracting the mixture at 90 to 95 ° C for 10 to 15 hours to prepare white water extract and Rhizoma extract ;
(c) Steatite and calyptium were heated at 90 ~ 100 ℃ for 3 ~ 5 minutes respectively, and then hot air dried at 50 ~ 60 ℃ for 32 ~ 40 hours. Water was added to the crushed and squeezed powder, To 95 < 0 > C for 6 to 10 hours to prepare an extract of Lycopersicon esculentum and Thunb.
(d) Pomegranate is immersed in vinegar, washed, taken out, washed with hot air at 50 to 60 ° C for 20 to 28 hours, water is added to crushed pomegranate powder, and extracted at 90 to 95 ° C for 3 to 5 hours Preparing a pomegranate extract;
(e) 16 to 24% by volume of the white water extract, 8 to 12% by volume of the Rhus japonica extract, 25 to 35% by volume of the extract of step (c) prepared in the step (b) , 8 to 12 vol.% Of the extract of calyx, and 25 to 35 vol.% Of the pomegranate extract prepared in the step (d), and concentrating the mixture to prepare a mixed concentrate; And
(f) adding 0.3 to 0.5% by volume of the mixed concentrate prepared in the step (e) to the extracted hot coffee of step (a). Way.
(a) 물에 L-카르니틴을 1~2%(w/v) 혼합하여 알칼리수를 제조하고, 커피 분말을 필터통에 채우고 상기 알칼리수를 부어 더치커피를 추출하는 단계;
(b) 백수오와 구절초를 각각 90~100℃에서 1~3분 동안 증열 처리하고 20~25℃에서 4~6시간 동안 그늘에서 건조하는 증열 및 건조하는 과정을 2~3회 반복한 후, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 백수오 분말과 구절초 분말에 물을 각각 12~18배(v/w)씩 첨가한 후 90~95℃에서 10~15시간 동안 추출하여 백수오 추출액 및 구절초 추출액을 제조하는 단계;
(c) 칡과 쇠별꽃을 각각 90~100℃에서 3~5분 동안 증열 처리한 후 50~60℃에서 32~40시간 동안 열풍건조하고 파쇄한 칡 분말과 쇠별꽃 분말에 물을 각각 12~18배(v/w)씩 첨가한 후 90~95℃에서 6~10시간 동안 추출하여 칡 추출액 및 쇠별꽃 추출액을 제조하는 단계;
(d) 석류를 0.8~1.2%(v/v) 식초물에 8~12분 동안 침지한 후 꺼내어 세척하고, 50~60℃에서 20~28시간 동안 열풍건조하고 파쇄한 석류 분말에 물을 12~18배(v/w)씩 첨가한 후 90~95℃에서 3~5시간 동안 추출하여 석류 추출액을 제조하는 단계;
(e) 혼합 추출액 총 부피 기준으로, 상기 (b)단계의 제조한 백수오 추출액 16~24 부피%, 구절초 추출액 8~12 부피%, 상기 (c)단계의 제조한 칡 추출액 25~35 부피%, 쇠별꽃 추출액 8~12 부피% 및 상기 (d)단계의 제조한 석류 추출액 25~35 부피%를 혼합한 혼합 추출액을 6~8 brix가 되도록 농축하여 혼합 농축액을 제조하는 단계; 및
(f) 상기 (a)단계의 추출한 더치커피에 상기 (e)단계에서 제조한 혼합 농축액을 0.3~0.5 부피% 첨가하는 단계를 포함하여 제조하는 것을 특징으로 하는 여성 갱년기 개선을 위한 더치커피의 제조방법.The method of claim 3,
(a) mixing alkaline water by mixing 1 to 2% (w / v) of L-carnitine in water, filling the filter case with the coffee powder, pouring the alkaline water to extract the instant coffee;
(b) repeating the process of steam-drying at 90 to 100 ° C for 1 to 3 minutes and drying at 20 to 25 ° C for 4 to 6 hours in shade for 2-3 times, Dried at 50 to 60 ° C for 20 to 28 hours and 12 to 18 times (v / w) of water were added to the crushed white powder and crushed red powder, respectively, followed by extraction at 90 to 95 ° C for 10 to 15 hours Preparing an extract of Bacillus subtilis and an extract of Bacillus subtilis;
(c) Steatite and calyptium were heated at 90 ~ 100 ℃ for 3 ~ 5 minutes and then hot air dried at 50 ~ 60 ℃ for 32 ~ 40 hours. Water was added 12 ~ 18 times (v / w), followed by extraction at 90 to 95 ° C for 6 to 10 hours to prepare an extract and a sphagnum ganoderma extract;
(d) Pomegranate is immersed in vinegar of 0.8-1.2% (v / v) for 8-12 minutes, washed out, washed with hot air at 50 ~ 60 ℃ for 20 ~ 28 hours, To 18 times (v / w), followed by extraction at 90 to 95 ° C for 3 to 5 hours to prepare a pomegranate extract;
(e) 16 to 24% by volume of the white water extract, 8 to 12% by volume of the Rhus japonica extract, 25 to 35% by volume of the extract of step (c) prepared in the step (b) , 8 to 12 vol.% Of the extract of calyx, and 25 to 35 vol.% Of the pomegranate extract prepared in step (d), to a concentration of 6 to 8 brix to prepare a mixed concentrate; And
(f) adding 0.3 to 0.5% by volume of the mixed concentrate prepared in the step (e) to the extracted hot coffee of step (a). Way.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180084891A KR101915031B1 (en) | 2018-07-20 | 2018-07-20 | Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020180084891A KR101915031B1 (en) | 2018-07-20 | 2018-07-20 | Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts |
Publications (1)
Publication Number | Publication Date |
---|---|
KR101915031B1 true KR101915031B1 (en) | 2018-11-06 |
Family
ID=64329519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020180084891A KR101915031B1 (en) | 2018-07-20 | 2018-07-20 | Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101915031B1 (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200105119A (en) * | 2019-02-28 | 2020-09-07 | 우석대학교 산학협력단 | Functional health drink for preventing female diseases and process for preparing the same |
KR20210029397A (en) * | 2019-09-06 | 2021-03-16 | 추영민 | A Detachable Manufacturing Apparatus of Functional Dutch Coffee |
KR20210059906A (en) * | 2019-11-18 | 2021-05-26 | 농업회사법인 주식회사 안동애에프엔에이치 | Method for manufacturing of kudzu vine mixed concentrate containing pomegranate |
KR20220085141A (en) * | 2020-12-15 | 2022-06-22 | 농업회사법인 주식회사 장수식품 | A composition for improving, preventing and treating of woman menopause related disease |
-
2018
- 2018-07-20 KR KR1020180084891A patent/KR101915031B1/en active IP Right Grant
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200105119A (en) * | 2019-02-28 | 2020-09-07 | 우석대학교 산학협력단 | Functional health drink for preventing female diseases and process for preparing the same |
KR102256014B1 (en) * | 2019-02-28 | 2021-05-25 | 우석대학교 산학협력단 | Functional health drink for preventing female diseases and process for preparing the same |
KR20210029397A (en) * | 2019-09-06 | 2021-03-16 | 추영민 | A Detachable Manufacturing Apparatus of Functional Dutch Coffee |
KR102292112B1 (en) * | 2019-09-06 | 2021-08-20 | 추영민 | A Detachable Manufacturing Apparatus of Functional Dutch Coffee |
KR20210059906A (en) * | 2019-11-18 | 2021-05-26 | 농업회사법인 주식회사 안동애에프엔에이치 | Method for manufacturing of kudzu vine mixed concentrate containing pomegranate |
KR102340850B1 (en) | 2019-11-18 | 2021-12-20 | 농업회사법인 주식회사 안동애에프엔에이치 | Method for manufacturing of kudzu vine mixed concentrate containing pomegranate |
KR20220085141A (en) * | 2020-12-15 | 2022-06-22 | 농업회사법인 주식회사 장수식품 | A composition for improving, preventing and treating of woman menopause related disease |
KR102541649B1 (en) | 2020-12-15 | 2023-06-20 | 농업회사법인 주식회사 장수식품 | A composition for improving, preventing and treating of woman menopause related disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101915031B1 (en) | Method for producing functional dutch coffee for relieving woman menopausal symptoms using Punica granatum fruit and Pueraria lobata root extracts | |
KR101691334B1 (en) | Method for producing red ginseng extract with enhanced ginsenoside content, red ginseng extract and red ginseng processed-food thereof | |
KR100730647B1 (en) | Aged Concentrate of Ginseng Steamed Red, and a Preparation Method Thereof | |
JPH0873369A (en) | Tea for health | |
KR102136052B1 (en) | Composition for Liver Protection Containing Hub Extract and Beverage Thereof | |
KR20170125744A (en) | Manufacturing method of high quality red platycodon and red platycodon thereof | |
KR20200106577A (en) | Composition for anti-oxidant, anti-inflammatory and relieving swelling containing plant complex extracts | |
Nirmala et al. | Promising underutilized wild plants of cold desert Ladakh, India for nutritional security and health benefits | |
CN110122803A (en) | A kind of Noni fruit piece and preparation method thereof | |
KR100678869B1 (en) | Method for manufacturing beverage by hovenia dulcis thunb | |
KR101788253B1 (en) | Composition for improving male sexual function comprising the extract of Alpinia Officinarum, Smilacina Japonica & Black Garlic | |
CN105559027A (en) | Melastoma dodecandrum fruit bechamel and preparation method thereof | |
KR20190057618A (en) | Ripe persimmon jelly comprising herbal ingredients and manufacturing method thereof | |
KR102168192B1 (en) | Healthful mixed tea development using fermented herbs, fruits and shiitake | |
KR20110080817A (en) | The healthy beverage manufactacturing method | |
KR102485016B1 (en) | Functional leached tea and manufacturing method of the same | |
KR20110018977A (en) | A drink with red ginseng and herbs | |
KR20190077802A (en) | Method for producing glutinous rice cake using persimmon, grain and medicinal plant | |
KR101375347B1 (en) | The method for manufacuting red ginseng drink with medicinal herb, and the red ginseng drink made by the method | |
KR101456127B1 (en) | A composition for increasing bone growth | |
KR102136053B1 (en) | Composition for Removing Hangover Comprising Herb Extract and Beverage Thereof | |
KR102485019B1 (en) | Functional leached tea and manufacturing method of the same | |
KR101192853B1 (en) | Method for preparing a drink comprising extract of ginseng and taraxacum platycarpum | |
KR101003463B1 (en) | A process forpreparing fermented soybean pills efficacious against atopic dermatitis | |
KR102623645B1 (en) | Method for producing a composition comprising atractylodis rhizoma alba for improvving heartbum and a composition comprising atractylodis rhizoma alba produced thereby |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |